Etoposide and cisplatin in combination with anlotinib for lung NUT carcinoma: a case report.

IF 3.5 3区医学 Q2 ONCOLOGY

Frontiers in Oncology Pub Date : 2025-09-17 eCollection Date: 2025-01-01 DOI:10.3389/fonc.2025.1632133

Yuxing Sun, Jiangyu Bian, Linfeng Wang, Tong Zhang

引用次数: 0

Abstract

Lung NUT carcinoma is a rare malignant tumor, which is highly aggressive, poorly differentiated, and difficult to recognize at an early stage, and is associated with very rare reports and extremely poor prognosis, with some reports showing a mOS of only 2.2 months. In this paper, we report the treatment of a rare case of primary lung NUT cancer. After surgery, chemotherapy and targeted therapy, the patient's progression-free survival is now more than 4 months, which provides a feasible treatment option for lung NUT cancer.

查看原文本刊更多论文

依托泊苷、顺铂联合安洛替尼治疗肺癌1例。

肺NUT癌是一种罕见的恶性肿瘤，侵袭性强，分化差，早期难以识别，报道非常罕见，预后极差，部分报道生存期仅为2.2个月。本文报告一例罕见的原发性肺NUT癌的治疗。经手术、化疗及靶向治疗，患者无进展生存期均在4个月以上，为肺癌NUT提供了一种可行的治疗选择。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Frontiers in Oncology Biochemistry, Genetics and Molecular Biology-Cancer Research

CiteScore

6.20

自引率

10.60%

发文量

6641

审稿时长

14 weeks

期刊介绍： Cancer Imaging and Diagnosis is dedicated to the publication of results from clinical and research studies applied to cancer diagnosis and treatment. The section aims to publish studies from the entire field of cancer imaging: results from routine use of clinical imaging in both radiology and nuclear medicine, results from clinical trials, experimental molecular imaging in humans and small animals, research on new contrast agents in CT, MRI, ultrasound, publication of new technical applications and processing algorithms to improve the standardization of quantitative imaging and image guided interventions for the diagnosis and treatment of cancer.